Cargando…
Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent
Post-transplant lymphoproliferative disorder (PTLD) is a rare complication seen in hematologic stem cell (HSC) and solid organ transplantation that results from immune suppressant medications needed to prevent allograft rejection. Epstein-Barr virus (EBV) has been implicated in a majority of these c...
Autores principales: | Patek, Bonnie, Strahotin, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919954/ https://www.ncbi.nlm.nih.gov/pubmed/31890402 http://dx.doi.org/10.7759/cureus.6200 |
Ejemplares similares
-
Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders
por: Karbasi-Afshar, R, et al.
Publicado: (2013) -
Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.
por: Nieto-Rios, John Fredy, et al.
Publicado: (2016) -
Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009) -
Post–Liver Transplant Lymphoproliferative Disorder Presenting as Biliary Stricture
por: Karb, Daniel, et al.
Publicado: (2021) -
Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)